What AOD-9604 is
AOD-9604 is a growth-hormone fragment analog discussed for body-composition effects without the full endocrine profile of GH itself.
AOD-9604 is grouped under Fitness + Recovery / Fat Loss + GLP-1s on PeptideFactCheck because it stays popular because it sounds like a fat-loss peptide with less hormonal baggage than classic GH-axis compounds.
The useful starting point is to separate the molecule itself from the internet story around it. It stays popular because it sounds like a fat-loss peptide with less hormonal baggage than classic GH-axis compounds.
Why people keep looking it up
It stays popular because it sounds like a fat-loss peptide with less hormonal baggage than classic GH-axis compounds.
AOD-9604 is a growth-hormone fragment analog discussed for body-composition effects without the full endocrine profile of GH itself.
AOD-9604 tends to stay in the conversation because it touches a familiar public theme: gh fragment, lipolysis discussion, and body composition. That makes it easy for the claim to travel faster than the evidence.
What the evidence can support right now
More studied than many research peptides, but still not an approved mainstream fat-loss medicine.
Some human investigation exists, but the broad internet fat-loss story still needs more careful interpretation.
Preclinical work and fragment-based rationale drive much of the remaining interest.
Why this page carries the current tier: More studied than many research peptides, but still not an approved mainstream fat-loss medicine.
The current seed trail for AOD-9604 is pulling from 1 literature source, 1 trials source, 1 databases source, and 1 safety source.
Safety, limits, and regulatory context
The gap between fragment pharmacology and actual durable fat-loss benefit remains important.
No current FDA-approved AOD-9604 product is represented in this seed set.
Editorial boundary: PeptideFactCheck does not publish dosing, cycling, sourcing, injection, or administration instructions for AOD-9604. The job here is to explain the public claim, the mechanism story, the evidence strength, and the current limits.
Molecular and identifier data
The current PubChem match for AOD-9604 is CID 71300630. That gives the page a source-backed chemistry record rather than a placeholder identifier block.
- PubChem CID
- 71300630
- Formula
- C78H123N23O23S2
- Molecular weight
- 1815.1
- InChIKey
- GVIYUKXRXPXMQM-BPXGDYAESA-N
Matched synonyms include AOD 9604, AOD9604, AOD-9604, RefChem:113278, Tyr-somatostatin (177-191), Somatostatin (177-191), Tyr-, Somatostatin (177-191), tyrosyl-, 221231-10-3.
Open PubChem recordClinical trial snapshot
The current ClinicalTrials.gov intervention query for AOD-9604 returns 0 study records. This does not prove efficacy by itself, but it does show whether the peptide is showing up in a formal trial registry rather than only in forums or vendor copy.
No linked intervention records were returned by the current ClinicalTrials.gov query terms for this page.
Literature snapshot
The current PubMed query for AOD-9604 returns 18 results. The articles below are a quick literature surface so the page shows actual papers instead of only generic evidence labels.
Source trail
Each linked source is shown directly so the page can be audited. The page now combines its editorial seed trail with automated official-source enrichment generated on 2026-04-24 from PubChem, ClinicalTrials.gov, PubMed, DailyMed, openFDA label, and Drugs@FDA.